What precautions should be taken for dental procedures in patients receiving Prolia (denosumab)?

Dental Precautions for Prolia (Denosumab) Patients

All patients on Prolia must undergo a comprehensive dental examination and complete any necessary invasive dental work BEFORE starting therapy, and invasive dental procedures should be avoided during active treatment. 1, 2, 3

Pre-Treatment Dental Assessment

Before initiating Prolia, patients require:

• Complete dental, periodontal, and oral radiographic examination
• Treatment of all active dental disease, particularly periodontitis and periapical infections
• Completion of any planned invasive procedures (extractions, implants, alveoloplasties) with full healing confirmed before first dose 3
• Delay Prolia initiation 14-21 days after invasive dental procedures to allow complete wound healing 4

Risk of Osteonecrosis of the Jaw (ONJ)

The ONJ risk with Prolia is 1-2% in cancer patients on oncologic doses 1, 2 and 2.3% in osteoporosis patients undergoing extractions 5—this is 7.7 times higher than oral bisphosphonates (0-0.3%). The risk increases with:

• Longer duration of therapy 6
• Pre-existing oral infections (periodontitis, periapical disease) 6
• Concurrent corticosteroid use 6
• Multiple extractions 5
• Female sex 6

During Active Prolia Treatment

Routine Dental Care

• Maintain excellent oral hygiene (brushing, flossing after meals, fluoride rinse) 4
• Schedule dental evaluations every 6 months 3
• Non-invasive procedures (cleanings, fillings, root canals without apicoectomy) can proceed safely

Invasive Procedures

Elective invasive procedures (extractions, implants, bone surgery) should NOT be performed during active Prolia therapy 3. However, if medically necessary:

1. Timing is critical: Perform procedures 4-7 months after the last Prolia injection when drug effect is waning 5, 7

   • Avoid procedures within 3 months of injection (highest ONJ risk) 7
   • The "therapeutic window" at 4-7 months post-injection minimizes both ONJ risk and fracture risk from prolonged drug interruption

2. Surgical technique:

   • Use minimally invasive approach 8
   • Smooth bone edges
   • Remove all infected/necrotic tissue thoroughly
   • Achieve tension-free primary closure using double-layered technique 9
   • Preserve local blood supply 8

3. Antibiotic prophylaxis: Administer preoperative IV antibiotics 9

4. Post-operative monitoring: Evaluate every 6-8 weeks until complete mucosal coverage achieved 3

5. Resuming Prolia: Delay next dose until dentist confirms complete healing 1, 2

Drug Holiday Controversy

Important caveat: Research shows that brief drug holidays (discontinuing Prolia before dental procedures) do NOT reduce ONJ risk 6. Unlike bisphosphonates, denosumab does not accumulate in bone and stopping it causes rapid bone turnover rebound with increased vertebral fracture risk 10. Therefore, do not routinely discontinue Prolia for dental procedures—instead, time procedures during the waning drug effect period (4-7 months post-injection).

Supplementation Requirements

All patients on Prolia require:

• Calcium supplementation
• Vitamin D supplementation
• Monitor serum calcium regularly (denosumab causes hypocalcemia in 13% of patients) 1, 2

Communication Protocol

Coordinate care between oncologist/prescribing physician and dentist, particularly regarding:

• Timing of procedures relative to dosing schedule
• Healing status before resuming therapy
• Any signs of exposed bone or delayed healing 3